These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38709689)

  • 1. Hidradenitis Suppurativa Found Associated With Cytokine Storm.
    Yang B; Temiz LA; Duran MA; Miller AC; Adjei S; Tyring SK; Wu T
    J Drugs Dermatol; 2024 May; 23(5):e134-e136. PubMed ID: 38709689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Regimen of IL-17A Inhibitor Secukinumab for the Remission of Severe Hidradenitis Suppurativa: Case Report.
    Gutierrez E; Issa N; Resnik B
    J Drugs Dermatol; 2022 Dec; 21(12):1358-1360. PubMed ID: 36468954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of adiponectin, leptin, resistin and visfatin in non-diabetics patients with hidradenitis suppurativa.
    González-López MA; Vilanova I; Ocejo-Viñals G; Arlegui R; Navarro I; Guiral S; Mata C; Pérez-Paredes MG; Portilla V; Corrales A; González-Vela MC; González-Gay MA; Blanco R; Hernández JL
    Arch Dermatol Res; 2020 Oct; 312(8):595-600. PubMed ID: 31786710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings Report of the Fifth Symposium on Hidradenitis Suppurativa Advances (SHSA) 2020.
    Schneider C; Adelman M; Almuhanna N; Sakya S; Delorme I; Hamzavi I; Kirby JS
    J Drugs Dermatol; 2021 Aug; 20(8):868-873. PubMed ID: 34397198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa.
    Akdogan N; Dogan S; Incel-Uysal P; Karabulut E; Topcuoglu C; Yalcin B; Atakan N
    Arch Dermatol Res; 2020 May; 312(4):255-262. PubMed ID: 31729595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.
    Masson R; Shih T; Jeong C; Shi VY; Hsiao JL
    J Drugs Dermatol; 2023 Aug; 22(8):785-794. PubMed ID: 37556513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cytokine levels in patients with hidradenitis suppurativa vary with race.
    McKay C; Kuraitis D; Murina A
    J Am Acad Dermatol; 2021 May; 84(5):1405-1406. PubMed ID: 32860911
    [No Abstract]   [Full Text] [Related]  

  • 8. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gluteal hidradenitis suppurativa presenting pemphigus-like findings: case report.
    Kurihara Y; Furue M
    BMC Dermatol; 2019 Jul; 19(1):11. PubMed ID: 31337387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Hormonal Therapy in Hidradenitis Suppurativa.
    Karagaiah P; Daveluy S; Ortega-Loayza A; Gulliver W; Szepietowski J; Grabbe S; Goldust M
    J Drugs Dermatol; 2023 Apr; 22(4):369-374. PubMed ID: 37026880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Alternative Medicine Users and Non-Users in Patients With Hidradenitis Suppurativa.
    Lane J; Emmerich V; Senthilnathan A; Kolli SS; Cardwell LA; Richardson IM; Feldman SR; Pichardo RO
    J Drugs Dermatol; 2021 Oct; 20(10):1072-1074. PubMed ID: 34636524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of Anakinra in a Case of Severe Hidradenitis Suppurativa.
    Russo V; Alikhan A
    J Drugs Dermatol; 2016 Jun; 15(6):772-4. PubMed ID: 27272089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of the Current Landscape of Hidradenitis Suppurativa Treatment Development.
    Westerkam L; Sayed C
    J Drugs Dermatol; 2023 Oct; 22(10):1021-1026. PubMed ID: 37801538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?
    Kanni T; Zenker O; Habel M; Riedemann N; Giamarellos-Bourboulis EJ
    Br J Dermatol; 2018 Aug; 179(2):413-419. PubMed ID: 29405257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa.
    Frew JW; Hawkes JE; Krueger JG
    F1000Res; 2018; 7():1930. PubMed ID: 30828428
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
    Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
    Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series.
    Baroudi B; Bashyam AM; Feldman SR; Pichardo RO
    J Drugs Dermatol; 2023 Nov; 22(11):e12-e16. PubMed ID: 37943259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa.
    Jiménez-Gallo D; de la Varga-Martínez R; Ossorio-García L; Albarrán-Planelles C; Rodríguez C; Linares-Barrios M
    Mediators Inflamm; 2017; 2017():2450401. PubMed ID: 28769536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease.
    Berman HS; Villa NM; Shi VY; Hsiao JL
    J Dermatolog Treat; 2021 Mar; 32(2):261-263. PubMed ID: 31389737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.